Abstract

ACP Journal Club17 August 2010Telaprevir combination therapy induced a sustained virologic response in nonresponsive chronic HCV infectionJuerg Reichen, MDJuerg Reichen, MDUniversity Clinic of Visceral Surgery and Medicine, Berne, Switzerland (J.R.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-153-4-201008170-02007 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationMcHutchison JG, Manns MP, Muir AJ, et al. Telaprevir for previously treated chronic HCV infection. N Engl J Med. 2010;362:1292-303. https://pubmed.ncbi.nlm.nih.gov/20375406Clinical Impact RatingsGastroenterology: Infectious Disease: References1 Kuntzen T, Timm J, Berical A, et al. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology. 2008;48:1769-78. [PMID: 19026009] Google Scholar2 Hézode C, Forestier N, Dusheiko G, et al. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med. 2009;360:1839-50. [PMID: 19403903] Google Scholar Author, Article, and Disclosure InformationAffiliations: University Clinic of Visceral Surgery and Medicine, Berne, Switzerland (J.R.)This article was published at Annals.org on 3 August 2010. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 17 August 2010Volume 153, Issue 4Page: JC2-7KeywordsAdverse eventsAnemiaChronic hepatitis CDrugsHepatitis AHepatitis CInfectious diseasesPatientsRashes ePublished: 17 August 2010 Issue Published: 17 August 2010 Copyright & PermissionsCopyright © 2010 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call